
Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
Step by step instructions to Appropriately Keep up with Your Sunlight powered chargers for Most extreme Productivity - 2
A photographer finds thousands of dinosaur footprints near Italian Winter Olympic venue - 3
The 10 Most Persuasive Forerunners in Innovation - 4
Herzog, German Chancellor Merz discuss final Gaza hostage, Arrow 3 exchange in Jerusalem - 5
PFAS in pregnant women’s drinking water puts their babies at higher risk, study finds
A Gastronomic Experience in Healthy Enjoyments: A Survey of \Nutritious and Tasty\ Solid Cooking Recipe Book
One spent $20 on candy. Another paid $700 for a custom costume. Here's how Halloween costs stacked up this year.
Satellite space quiz: What's orbiting Earth?
What is ‘Auld Lang Syne’? Why we sing this song at midnight on New Year’s Eve.
What's the new 'Knives Out' mystery about? Everything to know about 'Wake Up Dead Man,' including who's in the cast and what the reviews say.
Easter Island quarry reveals how Polynesians made enigmatic stone statues
21 Incredibly Interesting Contemplations To Observe Consistently
Instructions to Decide whether a Fender bender Legal counselor is Required for Your Particular Case
The Most Moving TED Talks You Want to Watch












